Other News on $DGRI Newly Formed Dutch Gold Subsid
Post# of 2561
Posted On: 06/17/2014 12:19:10 PM
Other News on $DGRI Newly Formed Dutch Gold Subsidiary, Ascendant Analytics, Inc. to Launch Consumer Potency Testing Product
http://finance.yahoo.com/news/newly-formed-du...00199.html
ATLANTA, GA / ACCESSWIRE / June 4, 2014 / Dutch Gold Resources, Inc. (DGRI.OTC), an emerging financial services company serving the medical marijuana “MMJ” industry, today announced that it has formed a new subsidiary, Ascendant Analytics, Inc. (AAI) which will produce and market a consumer potency testing kit for MMJ. The company anticipates the kits being available to consumers by year end.
According to the Marijuana Business Factbook 2014, 66% of all MMJ consumers believe that it is important to test for potency of their intended purchase, and 64% believe that it is important to test for safety. According to the same publication, the average annual consumer spend is $1,869 per year with the average consumer visiting a retailer three times per month.
The Company estimates that the market for test kits, priced reasonably to the consumer, could be seven to ten times the revenue of commercial MMJ laboratories, estimated by Factbook to be between $15 and $20 million this year. AAI intends to approach the retail market first, before expanding its product line to include other possible markets verticals.
Daniel Hollis, CEO of Dutch Gold Resources commented, “We have been evaluating this underserved market since early March. Our findings have lead us to believe that there is, and will continue to be, considerable demand for a reasonably priced consumer based retail test kit. Not only do we believe there significant consumer demand, but we also foresee heightened demand from manufacturers of edibles as individual states begin to demand batch testing.”
Hollis continued, “Our review of certain scientific data has given us cause to believe that AAI has the potential of uniquely serving both markets.” The Company expects to move from the current scientific prototype to a working prototype in order to test production in its third quarter of 2014, with commercial production expected by fourth quarter 2014.
http://finance.yahoo.com/news/newly-formed-du...00199.html
ATLANTA, GA / ACCESSWIRE / June 4, 2014 / Dutch Gold Resources, Inc. (DGRI.OTC), an emerging financial services company serving the medical marijuana “MMJ” industry, today announced that it has formed a new subsidiary, Ascendant Analytics, Inc. (AAI) which will produce and market a consumer potency testing kit for MMJ. The company anticipates the kits being available to consumers by year end.
According to the Marijuana Business Factbook 2014, 66% of all MMJ consumers believe that it is important to test for potency of their intended purchase, and 64% believe that it is important to test for safety. According to the same publication, the average annual consumer spend is $1,869 per year with the average consumer visiting a retailer three times per month.
The Company estimates that the market for test kits, priced reasonably to the consumer, could be seven to ten times the revenue of commercial MMJ laboratories, estimated by Factbook to be between $15 and $20 million this year. AAI intends to approach the retail market first, before expanding its product line to include other possible markets verticals.
Daniel Hollis, CEO of Dutch Gold Resources commented, “We have been evaluating this underserved market since early March. Our findings have lead us to believe that there is, and will continue to be, considerable demand for a reasonably priced consumer based retail test kit. Not only do we believe there significant consumer demand, but we also foresee heightened demand from manufacturers of edibles as individual states begin to demand batch testing.”
Hollis continued, “Our review of certain scientific data has given us cause to believe that AAI has the potential of uniquely serving both markets.” The Company expects to move from the current scientific prototype to a working prototype in order to test production in its third quarter of 2014, with commercial production expected by fourth quarter 2014.
(0)
(0)